Health experts claim that prostate cancer is the second most common type of cancer among men. It is also the sixth primary reason for deaths related to cancer among men across the globe. The load of prostate cancer is predicted to increase considerably with growing life expectancy in our nation. Experts say that the risk of being diagnosed with prostate cancer shoots up aggressively with age. Around 70 per cent of all prostate cancers occur among men who are above the age of 60 years.
In a significant number of prostate cancer incidents, it can be cured effectively if the disease is detected early, particularly with the arrival of a Nerve-Sparing Robotic Prostatectomy procedure. Whereas in the case of mild disease, the growth of the cancer is so steady that patients can manage to live for many years with nominal medication and treatment.
Standard medical recommendations instruct men who are older than 45 years to undergo an annual Serum PSA Evaluation as there are no definite symptoms of prostate cancer. If a family history of prostate cancer exists, men who are above the age of 40 years should undergo an annual Serum PSA Evaluation.
The course of antibiotics can regulate the elevated PSA
Experts say that the course of antibiotics can regulate the elevated PSA. In case, the repeat PSA as well is high or displays a growing trend after two weeks then tests like free PSA, PSA velocity, and PSA density can evaluate the odds of cancer. As per the guidelines, a trans-rectal ultrasound or a TRUS biopsy is an apt diagnostic tool for prostate cancer.
After the diagnosis of prostate cancer, it needs to be graded and staged. Experts claim that organ confined intimidate grade cancer is best cured with nerve-sparing robot-assisted radical prostatectomy to avert the common issues of impotence and incontinence that are quite frequent in other methods of surgical treatment. Advanced-stage cancer usually requires multimodality management.